NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity by Duo Xu, Shiyuan Yin, Yongqian Shu

Get full text

The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells by Lijun Wang, Luqun Tang, Chengyun Yao, Chunyan Liu, Yongqian Shu

Get full text

Exosome‐transmitted miR‐769‐5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53 by Xinming Jing, Mengyan Xie, Kun Ding, Tingting Xu, Yuan Fang, Pei Ma, Yongqian Shu

Get full text

Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop by Tingting Xu, Mengyan Xie, Xinming Jing, Huning Jiang, Xi Wu, Xinzhu Wang, Yongqian Shu

Get full text

Prognostic value of the albumin-bilirubin score in patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis by Wanying Cheng, Wanying Cheng, Limin Duan, Ji Xu, Yongqian Shu, Hongxia Qiu, Guangli Yin

Get full text

Prognostic value of lipid profile in adult hemophagocytic lymphohistiocytosis by Wanying Cheng, Wanying Cheng, Lingling Wang, Lingling Wang, Xin Gao, Limin Duan, Yongqian Shu, Hongxia Qiu, Hongxia Qiu

Get full text

Integration of multiple machine learning approaches develops a gene mutation-based classifier for accurate immunotherapy outcomes by Run Shi, Jing Sun, Zhaokai Zhou, Meiqi Shi, Xin Wang, Zhaojia Gao, Tianyu Zhao, Minglun Li, Yongqian Shu

Get full text

The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis. by Haina Du, Nannan Guo, Bin Shi, Qian Zhang, Zhipeng Chen, Kai Lu, Yongqian Shu, Tao Chen, Lingjun Zhu

Get full text

Hypoxia within tumor microenvironment characterizes distinct genomic patterns and aids molecular subtyping for guiding individualized immunotherapy by Run Shi, Jing Sun, Hanyu Zhou, Tong Hu, Zhaojia Gao, Xin Wang, Minglun Li, Zhaokai Zhou, Yongqian Shu

Get full text

The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications by Yunru Gu, Yuan Fang, Xi Wu, Tingting Xu, Tong Hu, Yangyue Xu, Pei Ma, Qiang Wang, Yongqian Shu

Get full text

IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination by Shuai Ying, Ningxia Wu, Yuting Ruan, Wen Ge, Pei Ma, Tongpeng Xu, Yongqian Shu, Yingwei Wang, Wen Qiu, Chenhui Zhao

Get full text

LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6A‐YTHDF2‐dependent manner by Yuan Fang, Xi Wu, Yunru Gu, Run Shi, Tao Yu, Yutian Pan, Jingxin Zhang, Xinming Jing, Pei Ma, Yongqian Shu

Get full text

JP1 normalizes tumor vasculature to suppress metastasis and facilitate drug delivery by inhibiting IL-8 by Jiahua Cui, Zhen Che, Lu Zou, Dongyin Chen, Zhan Xie, Kun Ding, Huning Jiang, Aiping Li, Jianwei Zhou, Yongqian Shu

Get full text

HDAC inhibitor SAHA enhances antitumor immunity via the HDAC1/JAK1/FGL1 axis in lung adenocarcinoma by Tao Yu, Yuan Fang, Yongqian Shu, Tong Hu, Tingting Xu, Duo Xu, Yunru Gu, Yang-Yue Xu, Hao-Yang Shen, Pei Ma

Get full text

METTL14 regulates CD8+T-cell activation and immune responses to anti‐PD‐1 therapy in lung cancer by Chongqi Sun, Jian Wang, Huixing Li, Luyao Liu, Yu Lin, Ling Zhang, Xianglong Zu, Yizhi Zhu, Yongqian Shu, Dong Shen, Qiong Wang, Yiqian Liu

Get full text

Fat mass and obesity-associated protein (FTO) mediated m6A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay by Xi Wu, Yuan Fang, Yunru Gu, Haoyang Shen, Yangyue Xu, Tingting Xu, Run Shi, Duo Xu, Jingxin Zhang, Kai Leng, Yongqian Shu, Pei Ma

Get full text

An oncogene regulating chromatin favors response to immunotherapy<subtitle>Oncogene CHAF1A and immunotherapy outcomes</subtitle> by Leqian Ying, Zhangmin Hu, Yi Lu, Qing Tao, Fen Xiong, Yongqian Shu, Yufei Yang, Xuehan Qiao, Chen Peng, Yuchun Jiang, Miao Han, Min Xu, Xiaoqin Li, Deqiang Wang

Get full text

Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study by Tongpeng Xu, Tian Tian, Chen Wang, Xiaofeng Chen, Xiangrong Zuo, Hanyu Zhou, Jianan Bai, Chenhui Zhao, Sujie Fu, Chongqi Sun, Ting Wang, Ling Zhu, Jingzhi Zhang, Enxiu Wang, Ming Sun, Yongqian Shu

Get full text

Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: a proto... by Yizhang Chen, Yizhang Chen, Jiaguang Zhang, Gaohua Han, Jie Tang, Fen Guo, Wei Li, Li Xie, Hao Xu, Xinyi Zhang, Yitong Tian, Lanlan Pan, Yongqian Shu, Ling Ma, Xiaofeng Chen, Xiaofeng Chen

Get full text

Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study by Lin Shen, Qing Zhou, Ting Sun, Jie Wang, Hongming Pan, Yi-Long Wu, Jun Zhao, Jun Guo, Qingyuan Zhang, Ying Yuan, Yuxian Bai, Tianshu Liu, Yongqian Shu, Siyang Wang, Aiping Zhou, Dingwei Ye, Yujuan Gao, Silu Yang, Zuobai Wang

Get full text